Who owns MOLECULIN BIOTECH INC?
- Ticker: MBRX
- CUSIP Number: 60855d408
Tip: Access positions for across all investors
Analyze quarterly positions in Moleculin Biotech with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Moleculin Biotech stock
Who bought or sold MOLECULIN BIOTECH INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Geode Capital Management | 32k | $74k | 114% | Mar 2026 |
|
| Vanguard Group | 16k | $51k | 100% | Dec 2025 |
|
| Vanguard Capital Management | 14k | $32k | 100% | Mar 2026 |
|
| Hrt Financial | 14k | $31k | 100% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 6.1k | $14k | 100% | Mar 2026 |
|
| Rockefeller Capital Management | 4.4k | $10k | 1928% | Mar 2026 |
|
| UBS Group | 3.4k | $7.8k | -42% | Mar 2026 |
|
| Tower Research Capital | 1.4k | $4.6k | 100% | Dec 2025 |
|
| BlackRock | 491.00 | $1.1k | -1% | Mar 2026 |
|
| EFG International | 434.00 | $1.4k | 100% | Dec 2025 |
|
| Pinnacle Wealth Planning Services | 281.00 | $643.012300 | 0% | Mar 2026 |
|
| Newbridge Financial Services Group | 114.00 | $261.003000 | 0% | Mar 2026 |
|
| SBI Securities | 43.00 | $98.001300 | 48% | Mar 2026 |
|
| Morgan Stanley | 36.00 | $82.800000 | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 24.00 | $55.000800 | 100% | Mar 2026 |
|
| Danske Bank A/s | 2.00 | $5.000000 | 0% | Mar 2026 |
|
| Caitong International Asset Management | 2.00 | $5.000000 | 100% | Mar 2026 |
|
| Advisor Group Holdings | 1.00 | $3.000000 | 100% | Dec 2025 |
|
| CVA Family Office | 1.00 | $2.000000 | 0% | Mar 2026 |
|
Who sold out of Moleculin Biotech?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Dec 2025 | 33k | $110k |
| Jane Street | Dec 2025 | 23k | $75k |